Testing direct oral anticoagulants: embedding in structured long-term care.

about

Testing direct oral anticoagulants: embedding in structured long-term care.

Item

http://www.wikidata.org/entity/Q50141412

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Testing direct oral anticoagulants: embedding in structured long-term care.

@en

Testing direct oral anticoagulants: embedding in structured long-term care.

@nl

type

Item

label

Testing direct oral anticoagulants: embedding in structured long-term care.

@en

Testing direct oral anticoagulants: embedding in structured long-term care.

@nl

prefLabel

Testing direct oral anticoagulants: embedding in structured long-term care.

@en

Testing direct oral anticoagulants: embedding in structured long-term care.

@nl

P1476

Testing direct oral anticoagulants: embedding in structured long-term care.

@en

P2093

Hugo Ten Cate

http://www.w3.org/2001/XMLSchema#string

P2860

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.

Evolving use of new oral anticoagulants for treatment of venous thromboembolism

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Implementation of non-vitamin K antagonist oral anticoagulants in daily practice: the need for comprehensive education for professionals and patients

Laboratory Assessment of Direct Oral Anticoagulants.

[Prevalence of atrial fibrillation, treatment eligibility and consumption of oral anticoagulants in Italian Local Health Authorities: impact of non-vitamin K antagonist oral anticoagulants].

Real-world variability in dabigatran levels in patients with atrial fibrillation.

Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL.

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

P304

1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2450/2017.0197-17

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29106353

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

6125238

http://www.w3.org/2001/XMLSchema#string